DuPont acquired OxyMem, a developer of membrane aerated biofilm reactor (MABR) technology for wastewater treatment, and Desalitech, a provider of closed-circuit reverse osmosis (CCRO) solutions. The acquisitions expand DuPont's water treatment portfolio into secondary wastewater treatment and high-recovery RO systems.
DuPont has signed an agreement to acquire Desalitech Ltd., a closed circuit reverse osmosis (CCRO) company, to enhance its water purification portfolio.
DuPont acquired Desalitech on December 11, 2019. The terms of the transaction were not disclosed.
DuPont has signed an agreement to acquire Desalitech Ltd., a closed circuit reverse osmosis company. The transaction is expected to close in January 2020. Financial terms were not disclosed.
DuPont has signed an agreement to acquire Desalitech, an Israeli company specializing in closed circuit reverse osmosis (CCRO) technology for water treatment. The transaction is expected to close in January 2020; financial terms were not disclosed.